Merck KGaA
About Merck KGaA
Merck KGaA is a global science and technology company operating across life science, healthcare, and electronics. It translates scientific research into innovative tools, products, and partnerships that aim to advance health and technology worldwide. Headquartered in Darmstadt, Germany, the company serves customers globally and emphasizes digital innovation and sustainable practices. The branding emphasizes a vibrant, transformative approach to science and technology while maintaining a strong regional and international presence.
Recent News
Sanofi MS Drug Rejected in US Gets an Endorsement in Europe
Farther Finance Advisors LLC Raises Holdings in Merck & Co., Inc. $MRK
This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
Pharma and Biotech Layoffs 2026 Watch
Merck KGaA Acquires JSR Chromatography Business
Sanofi Posts Upbeat Sales as R&D Pressure Builds
StockWatch: Trump Order Lifts Psychedelic Drug Shares
What Does 17 Pharma MFN Deals Are Underneath the Press Releases: The Real Primary Source Stack, the GLP1 Numbers, TrumpRX Plumbing, and Where the New Adjudication Layer Gets Monetized
Merck’s PD-1/VEGF Data Star in Stacked Lineup of AACR ‘26 Data Reveals
New Data Build Case for Roche's Oral BTK Drug for MS
Biocytogen and Sihuan Pharmaceutical Partner to Discover Novel Therapeutics in Multiple Indications
BMS Makes a Beeline, Bringing 5 Assets to Biotech's $300M Precision Immunology Debut
Sanofi Defends Dupixent Patents, but Execs Insist It Has Nothing to Do with CEO Change
After Buying HUB and Partnering with Promega, MilliporeSigma Charts Growth Path in Organoids